215 related articles for article (PubMed ID: 25707023)
21. A novel mutation in the SLC19A2 gene in a Turkish female with thiamine-responsive megaloblastic anemia syndrome.
Yeşilkaya E; Bideci A; Temizkan M; Kaya Z; Camurdan O; Koç A; Bozkaya D; Koçak U; Cinaz P
J Trop Pediatr; 2009 Aug; 55(4):265-7. PubMed ID: 18614593
[TBL] [Abstract][Full Text] [Related]
22. Pancytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
Moulin V; Grandoni F; Castioni J; Lu H
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29903777
[TBL] [Abstract][Full Text] [Related]
23. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.
Onal H; Bariş S; Ozdil M; Yeşil G; Altun G; Ozyilmaz I; Aydin A; Celkan T
Turk J Pediatr; 2009; 51(3):301-4. PubMed ID: 19817279
[TBL] [Abstract][Full Text] [Related]
24. Recurrent psychiatric manifestations in thiamine-responsive megaloblastic anemia syndrome due to a novel mutation c.63_71 delACCGCTC in the gene SLC19A2.
Wood MC; Tsiouris JA; Velinov M
Psychiatry Clin Neurosci; 2014 Jun; 68(6):487. PubMed ID: 24520986
[No Abstract] [Full Text] [Related]
25. Thiamine-responsive megaloblastic anemia syndrome: a novel mutation.
Yilmaz Agladioglu S; Aycan Z; Bas VN; Peltek Kendirci HN; Onder A
Genet Couns; 2012; 23(2):149-56. PubMed ID: 22876572
[TBL] [Abstract][Full Text] [Related]
26. Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood.
Olsen BS; Hahnemann JM; Schwartz M; Østergaard E
Pediatr Diabetes; 2007 Aug; 8(4):239-41. PubMed ID: 17659067
[TBL] [Abstract][Full Text] [Related]
27. Thiamine responsive megaloblastic anemia with a novel SLC19A2 mutation presenting with myeloid maturational arrest.
Dua V; Yadav SP; Kumar V; Khan AA; Puri R; Verma I; Flanagan SE; Ellard S; Sachdeva A
Pediatr Blood Cancer; 2013 Jul; 60(7):1242-3. PubMed ID: 23512295
[No Abstract] [Full Text] [Related]
28. An Adult Case of Thiamine-Sensitive Megaloblastic Anemia Syndrome Accidentally Diagnosed Myelodysplastic Syndrome.
Kutlucan A
J Coll Physicians Surg Pak; 2019 Jun; 29(6):S13-S15. PubMed ID: 31142407
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia.
Zhang S; Qiao Y; Wang Z; Zhuang J; Sun Y; Shang X; Li G
Clin Chim Acta; 2021 May; 516():157-168. PubMed ID: 33571483
[TBL] [Abstract][Full Text] [Related]
30. Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child.
Khurshid A; Fatimah S; Altaf C; Malik HS; Sajjad Z; Khadim MT
J Coll Physicians Surg Pak; 2018 Sep; 28(9):S169-S171. PubMed ID: 30173687
[TBL] [Abstract][Full Text] [Related]
31. [Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].
Lu H; Lu H; Vaucher J; Tran C; Vollenweider P; Castioni J
Rev Med Interne; 2019 Jan; 40(1):20-27. PubMed ID: 30031565
[TBL] [Abstract][Full Text] [Related]
32. Thiamine-responsive megaloblastic anaemia.
Veetil VM; Pachat D; Nikitha K; Kutty JM
Natl Med J India; 2023; 36(5):314-315. PubMed ID: 38759983
[TBL] [Abstract][Full Text] [Related]
33. Thiamine-responsive megaloblastic anemia syndrome with Ebstein anomaly: a case report.
Akbari MT; Zare Karizi S; Mirfakhraie R; Keikhaei B
Eur J Pediatr; 2014 Dec; 173(12):1663-5. PubMed ID: 24357267
[TBL] [Abstract][Full Text] [Related]
34. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.
Shaw-Smith C; Flanagan SE; Patch AM; Grulich-Henn J; Habeb AM; Hussain K; Pomahacova R; Matyka K; Abdullah M; Hattersley AT; Ellard S
Pediatr Diabetes; 2012 Jun; 13(4):314-21. PubMed ID: 22369132
[TBL] [Abstract][Full Text] [Related]
35. Loss-of-Function Mutation in Thiamine Transporter 1 in a Family With Autosomal Dominant Diabetes.
Jungtrakoon P; Shirakawa J; Buranasupkajorn P; Gupta MK; De Jesus DF; Pezzolesi MG; Panya A; Hastings T; Chanprasert C; Mendonca C; Kulkarni RN; Doria A
Diabetes; 2019 May; 68(5):1084-1093. PubMed ID: 30833467
[TBL] [Abstract][Full Text] [Related]
36. Beta cell function and clinical course in three siblings with thiamine-responsive megaloblastic anemia (TRMA) treated with thiamine supplementation.
Potter K; Wu J; Lauzon J; Ho J
J Pediatr Endocrinol Metab; 2017 Feb; 30(2):241-246. PubMed ID: 28076318
[TBL] [Abstract][Full Text] [Related]
37. Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia.
Bouyahia O; Ouderni M; Ben Mansour F; Matoussi N; Khaldi F
Ann Endocrinol (Paris); 2009 Dec; 70(6):477-9. PubMed ID: 19922902
[TBL] [Abstract][Full Text] [Related]
38. Thiamine transporter mutation: an example of monogenic diabetes mellitus.
Alzahrani AS; Baitei E; Zou M; Shi Y
Eur J Endocrinol; 2006 Dec; 155(6):787-92. PubMed ID: 17132746
[TBL] [Abstract][Full Text] [Related]
39. Thiamine-responsive megaloblastic anemia syndrome: long term follow-up.
Borgna-Pignatti C; Azzalli M; Pedretti S
J Pediatr; 2009 Aug; 155(2):295-7. PubMed ID: 19619756
[TBL] [Abstract][Full Text] [Related]
40. Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families.
Ricketts CJ; Minton JA; Samuel J; Ariyawansa I; Wales JK; Lo IF; Barrett TG
Acta Paediatr; 2006 Jan; 95(1):99-104. PubMed ID: 16373304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
